Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Concise GO annotation research for human HSPA12A / UniProt O43301. Focus on: whether HSPA12A has experimentally supported canonical HSP70 chaperone/protein-folding activity; ATP/ADP-sensitive interaction with SORL1/SorLA cytosolic tail; effects on SORL1 internalization, subcellular localization, APP/amyloid context only where relevant; cellular localization evidence; disease/tissue signaling studies only if they change GO annotation; caveats for generic protein binding and high-throughput HSPA12B transferred interactions. Include PMID/DOI citations and keep under 1500 words.

Concise GO annotation research report: Human HSPA12A (UniProt O43301)

Scope and key questions

This report evaluates whether HSPA12A has experimentally supported canonical HSP70 chaperone/protein-folding activity, and summarizes experimentally demonstrated interactions and trafficking effects with SORL1/SorLA, including ATP/ADP sensitivity, plus subcellular localization evidence relevant to GO annotation. Claims are restricted to evidence in the retrieved primary literature (notably Madsen et al., 2019) and selected contextual sources.

Table: This table summarizes GO-relevant experimental evidence for human HSPA12A, emphasizing what is directly supported versus what remains too weak for annotation. It is useful for distinguishing specific SorLA trafficking evidence from unsupported assumptions of canonical HSP70 chaperone activity.

1) Key concepts and definitions (GO-relevant)

Canonical HSP70 chaperone activity typically implies (i) ATP binding/hydrolysis by a nucleotide-binding domain (NBD), (ii) nucleotide-regulated substrate binding/release by a substrate-binding domain (SBD), and (iii) measurable chaperone outcomes (e.g., prevention of aggregation, protein refolding) often modulated by HSP40/J-domain proteins and nucleotide exchange factors. A molecular chaperone definition emphasizing controlled binding/release to stabilize unstable conformers and influence folding/assembly/transport is summarized in a recent review of heat shock protein networks (Melikov & Novák, 2024; published 2024-01; https://doi.org/10.14712/fb2024070030152) (melikov2024heatshockprotein pages 1-3).

GO implication: For HSPA12A, assigning GO molecular function terms like ATPase activity or protein folding chaperone generally requires direct enzymatic ATPase assays and/or client protein folding/refolding/aggregation assays, not solely membership in an HSP70-like sequence family or nucleotide-sensitive binding to one partner.

2) Does HSPA12A have experimentally supported canonical HSP70 ATPase/chaperone/protein-folding activity?

Current evidence in retrieved primary literature is insufficient to support canonical HSP70 chaperone/protein-folding activity for HSPA12A.

Foundational characterization: HspA12A (and HspA12B) were originally described as distant members of the Hsp70 family with an “atypical Hsp70 ATPase domain” based on conserved domain searches and sequence similarity (Han et al., 2003, PNAS; published 2003-02-04; https://doi.org/10.1073/pnas.252764399) (han2003twohsp70family pages 1-2). This supports family relationship but does not establish ATP hydrolysis or refolding activity.

Functional papers examined: A study in hepatocellular carcinoma identifies HSPA12A as an HSP70-family protein and reports direct binding to PCNA with an effect on PCNA trimerization and tumor phenotypes, but the provided text contains no ATPase assays and no refolding/aggregation suppression assays (Cheng et al., 2020, FEBS J; published online 2020-03; https://doi.org/10.1111/febs.15276) (cheng2020heat‐shockproteina12a pages 1-3).

SorLA study: Madsen et al. interpret nucleotide-sensitive SorLA binding as “similar to other HSPs regarding ADP dependent substrate binding,” but they do not report direct ATPase kinetics or canonical folding/refolding assays for HSPA12A (Madsen et al., 2019) (madsen2019hspa12atargetsthe pages 7-9, madsen2019hspa12atargetsthe pages 1-2).

Conclusion for GO MF: Based on the retrieved evidence, HSPA12A should not be annotated as a canonical HSP70 chaperone (e.g., ATP hydrolysis activity, unfolded protein binding, protein folding chaperone) on experimental grounds alone; the strongest experimental support is instead nucleotide-modulated binding to a specific partner (SORL1/SorLA tail) (madsen2019hspa12atargetsthe pages 2-3, madsen2019hspa12atargetsthe pages 5-7).

3) ATP/ADP-sensitive interaction with SORL1/SorLA cytosolic tail

Primary evidence: Madsen et al. (Scientific Reports, 2019-01) identify HSPA12A as a SorLA (SORL1) cytosolic-domain binding partner and provide multiple orthogonal assays supporting specificity and nucleotide modulation (https://doi.org/10.1038/s41598-018-37336-6) (madsen2019hspa12atargetsthe pages 2-3).

Interaction discovery and specificity
- Yeast two-hybrid (Y2H) screen using an adult human brain cDNA library identified HSPA12A prey clones interacting with SorLA cytosolic domain; importantly, the related paralog HSPA12B was negative in Y2H, supporting no automatic paralog transfer (madsen2019hspa12atargetsthe pages 2-3).
- GST pull-down with full-length recombinant GST-HSPA12A pulled down full-length SorLA from HEK293 lysates; GST alone did not (madsen2019hspa12atargetsthe pages 2-3).
- Specificity within the Vps10p-domain receptor family was supported by failure to detect binding to Sortilin and other tested receptors in the reported assays (madsen2019hspa12atargetsthe pages 5-7).

Nucleotide sensitivity (ATP/ADP modulation)
- Pull-downs performed with nucleotide titrations showed ADP increased SorLA precipitation while ATP decreased it, consistent with an HSP70-like nucleotide-regulated binding mode (madsen2019hspa12atargetsthe pages 2-3, madsen2019hspa12atargetsthe pages 5-7).
- Figure evidence for the nucleotide-dependence is captured in the cropped figure panels (madsen2019hspa12atargetsthe media 335a8308, madsen2019hspa12atargetsthe media c051a9b6, madsen2019hspa12atargetsthe media 6d1a2daf).

Binding site mapping on SorLA cytosolic tail
- Y2H truncations and mutagenesis mapped binding dependence to a region (reported as G29–P50 in the excerpt) containing acidic clusters, with strong dependence on the pentameric acidic cluster E34–D38 and the D47D48 motif (madsen2019hspa12atargetsthe pages 7-9, madsen2019hspa12atargetsthe pages 2-3).
- The D47D48 motif overlaps a reported GGA2 binding site, raising a mechanistic possibility of adaptor competition (important caveat for GO process inference) (madsen2019hspa12atargetsthe pages 7-9, madsen2019hspa12atargetsthe pages 3-5).

GO implication: This supports a curated annotation for specific protein binding to SORL1/SorLA cytosolic domain, and a mechanistic note that binding is ATP/ADP sensitive (madsen2019hspa12atargetsthe pages 2-3).

4) Effects on SORL1/SorLA internalization and subcellular localization (APP/amyloid context only where relevant)

Madsen et al. experimentally link HSPA12A binding to functional trafficking changes in SorLA.

SorLA internalization/endocytosis
- Using an antibody uptake/internalization time course in HEK293 cells, HSPA12A expression delayed SorLA internalization, with surface SorLA persisting longer in the presence of HSPA12A (madsen2019hspa12atargetsthe pages 5-7).
- Figure evidence showing delayed internalization is present in the retrieved crops (madsen2019hspa12atargetsthe media 335a8308, madsen2019hspa12atargetsthe media c051a9b6, madsen2019hspa12atargetsthe media 6d1a2daf).

SorLA subcellular distribution/localization
- Immunofluorescence/live imaging and biochemical fractionation indicated HSPA12A constrained SorLA into dense perinuclear compartments/vesicles and shifted SorLA into denser vesicle fractions on sucrose gradients (madsen2019hspa12atargetsthe pages 3-5).
- Figure crops demonstrating SorLA redistribution to perinuclear compartments are included among retrieved images (madsen2019hspa12atargetsthe media 335a8308, madsen2019hspa12atargetsthe media c051a9b6, madsen2019hspa12atargetsthe media 6d1a2daf).

APP/amyloid relevance: SorLA is an APP receptor encoded by SORL1, a major Alzheimer’s disease risk gene. In this dataset, HSPA12A effects are established at the level of SorLA trafficking; direct effects on APP processing/amyloid output were not required to support the GO-relevant trafficking statements and were not the focus of the extracted evidence (madsen2019hspa12atargetsthe pages 1-2, madsen2019hspa12atargetsthe pages 5-7).

GO implication: Evidence supports cautious biological process annotations around regulation of receptor internalization/trafficking in the SorLA system, but the mechanism could be via adaptor competition (e.g., with GGA2/AP adaptors) rather than chaperone-mediated folding (madsen2019hspa12atargetsthe pages 7-9, madsen2019hspa12atargetsthe pages 3-5).

5) HSPA12A cellular localization evidence (GO cellular component)

The strongest localization evidence in the retrieved context comes from Madsen et al. (2019).

Cytosol and nucleus
- Western blotting of detergent soluble/insoluble fractions and immunofluorescence supported that HSPA12A is present in cytosol and nucleus (madsen2019hspa12atargetsthe pages 7-9, madsen2019hspa12atargetsthe pages 3-5).

Vesicular/perinuclear association (SorLA-positive vesicles)
- In primary cortical astrocytes, immunofluorescence showed partial co-localization of endogenous cytoplasmic HSPA12A with SorLA in vesicular structures (madsen2019hspa12atargetsthe pages 5-7, madsen2019hspa12atargetsthe pages 3-5).
- Live imaging of GFP-tagged HSPA12A in HEK293 cells showed prominent signal in large perinuclear vesicles and smaller mobile vesicles (madsen2019hspa12atargetsthe pages 3-5).

GO implication: Cellular component annotations supported by direct evidence include cytosol and nucleus, with cautious support for association with perinuclear vesicular/endosomal compartments (the precise endosome subtype is not firmly established by the excerpted evidence) (madsen2019hspa12atargetsthe pages 5-7, madsen2019hspa12atargetsthe pages 3-5).

6) Caveats relevant to GO curation

1. Do not infer canonical HSP70 chaperone/protein-folding activity from sequence family assignment or nucleotide-sensitive binding alone; direct ATPase and refolding assays were not identified in the retrieved evidence (han2003twohsp70family pages 1-2, cheng2020heat‐shockproteina12a pages 1-3, madsen2019hspa12atargetsthe pages 1-2).
2. Avoid generic “protein binding” over-annotation. The best-supported specific binding partner in the retrieved primary literature is SorLA/SORL1 cytosolic tail, mapped to defined acidic motifs, and shown to be nucleotide-sensitive (madsen2019hspa12atargetsthe pages 2-3).
3. Avoid transferring high-throughput or paralog interactions from HSPA12B to HSPA12A. In the SorLA study, HSPA12B was explicitly negative in Y2H, emphasizing paralog specificity (madsen2019hspa12atargetsthe pages 2-3).
4. Overexpression/heterologous-system limitations: Many trafficking/localization effects were measured in HEK293 transfectants, and localization includes tagged HSPA12A constructs; these are strong for mechanistic hypotheses but should be curated with appropriate evidence codes and caution (madsen2019hspa12atargetsthe pages 10-11).

7) “Recent developments” (2023–2024) in the retrieved context and GO relevance

The retrieved 2023–2024 HSPA12A studies in other disease contexts (e.g., metabolism/signaling, lactylation pathways) were not necessary to establish the SorLA trafficking mechanism and generally do not provide direct canonical HSP70 chaperone assays in the provided excerpts (e.g., Li et al., 2024; https://doi.org/10.1007/s00018-024-05427-5) (li2024hspa12apromotescmyc pages 1-3). A 2024 heat shock protein network review provides updated conceptual framing for chaperone mechanisms but is not specific evidence for HSPA12A’s molecular function (Melikov & Novák, 2024; https://doi.org/10.14712/fb2024070030152) (melikov2024heatshockprotein pages 1-3).

Suggested GO-annotation takeaways (evidence-bounded)

• Molecular function: support SORL1/SorLA cytosolic-tail binding (nucleotide-modulated interaction) (madsen2019hspa12atargetsthe pages 2-3, madsen2019hspa12atargetsthe pages 5-7).
• Biological process: support conservative annotation related to SorLA receptor internalization/trafficking regulation based on delayed internalization and relocalization (madsen2019hspa12atargetsthe pages 5-7, madsen2019hspa12atargetsthe media 335a8308).
• Cellular component: support cytosol and nucleus, and cautious association with perinuclear vesicular/endosomal structures (madsen2019hspa12atargetsthe pages 3-5, madsen2019hspa12atargetsthe pages 5-7).
• Not supported (from retrieved evidence): canonical HSP70 ATPase activity and protein folding chaperone activity (han2003twohsp70family pages 1-2, cheng2020heat‐shockproteina12a pages 1-3, madsen2019hspa12atargetsthe pages 1-2).

References

1. (han2003twohsp70family pages 1-2): Zhihua Han, Quynh A. Truong, Shirley Park, and Jan L. Breslow. Two hsp70 family members expressed in atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America, 100:1256-1261, Jan 2003. URL: https://doi.org/10.1073/pnas.252764399, doi:10.1073/pnas.252764399. This article has 158 citations and is from a highest quality peer-reviewed journal.

2. (cheng2020heat‐shockproteina12a pages 1-3): Hao Cheng, Xiaofei Cao, Xinxu Min, Xiaojin Zhang, Qiuyue Kong, Qian Mao, Rongrong Li, Bin Xue, Lei Fang, Li Liu, and Zhengnian Ding. Heat‐shock protein a12a is a novel pcna‐binding protein and promotes hepatocellular carcinoma growth. The FEBS Journal, 287:5464-5477, Mar 2020. URL: https://doi.org/10.1111/febs.15276, doi:10.1111/febs.15276. This article has 19 citations.

3. (madsen2019hspa12atargetsthe pages 2-3): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

4. (madsen2019hspa12atargetsthe pages 3-5): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

5. (madsen2019hspa12atargetsthe pages 5-7): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

6. (madsen2019hspa12atargetsthe pages 10-11): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

7. (madsen2019hspa12atargetsthe media 335a8308): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

8. (madsen2019hspa12atargetsthe pages 1-2): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

9. (madsen2019hspa12atargetsthe pages 7-9): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

10. (melikov2024heatshockprotein pages 1-3): Aleksandr Melikov and Petr Novák. Heat shock protein network: the mode of action, the role in protein folding and human pathologies. Folia biologica, 70 3:152-165, Jan 2024. URL: https://doi.org/10.14712/fb2024070030152, doi:10.14712/fb2024070030152. This article has 11 citations and is from a peer-reviewed journal.

11. (madsen2019hspa12atargetsthe media c051a9b6): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

12. (madsen2019hspa12atargetsthe media 6d1a2daf): Peder Madsen, Toke Jost Isaksen, Piotr Siupka, Andrea E. Tóth, Mette Nyegaard, Camilla Gustafsen, and Morten S. Nielsen. Hspa12a targets the cytoplasmic domain and affects the trafficking of the amyloid precursor protein receptor sorla. Scientific Reports, Jan 2019. URL: https://doi.org/10.1038/s41598-018-37336-6, doi:10.1038/s41598-018-37336-6. This article has 16 citations and is from a peer-reviewed journal.

13. (li2024hspa12apromotescmyc pages 1-3): Yunfan Li, Xinxu Min, Xiaojin Zhang, Xiaofei Cao, Qiuyue Kong, Qian Mao, Hao Cheng, Liming Gou, Yuehua Li, Chuanfu Li, Li Liu, and Zhengnian Ding. Hspa12a promotes c-myc lactylation-mediated proliferation of tubular epithelial cells to facilitate renal functional recovery from kidney ischemia/reperfusion injury. Cellular and Molecular Life Sciences: CMLS, Sep 2024. URL: https://doi.org/10.1007/s00018-024-05427-5, doi:10.1007/s00018-024-05427-5. This article has 23 citations.

Citations

1. melikov2024heatshockprotein pages 1-3
2. https://doi.org/10.1073/pnas.252764399.
3. https://doi.org/10.1111/febs.15276
4. https://doi.org/10.1038/s41598-018-37336-6
5. https://doi.org/10.14712/fb2024070030152
6. https://doi.org/10.1073/pnas.252764399
7. https://doi.org/10.1007/s00018-024-05427-5
8. https://doi.org/10.1073/pnas.252764399,
9. https://doi.org/10.1111/febs.15276,
10. https://doi.org/10.1038/s41598-018-37336-6,
11. https://doi.org/10.14712/fb2024070030152,
12. https://doi.org/10.1007/s00018-024-05427-5,

HSPA12A: A Divergent Non-Canonical HSP70 Lacking ATP-Dependent Protein Folding Chaperone Machinery

Executive Judgment

Verdict: Supported — HSPA12A is a divergent non-canonical HSP70 for which GO:0140662 (ATP-dependent protein folding chaperone) should NOT be assigned.

HSPA12A retains an actin-like ATPase-fold nucleotide-binding domain (NBD) that places it in the HSP70 superfamily on architectural grounds, but it completely lacks the molecular machinery required for canonical ATP-dependent protein folding chaperone activity. Eleven convergent lines of evidence — spanning sequence analysis, domain architecture, structural homology, co-chaperone interface analysis, and published functional studies — demonstrate that HSPA12A cannot perform the HSP70 chaperone cycle. Specifically: (1) all three PROSITE HSP70 diagnostic signatures are absent; (2) the substrate-binding domain (both SBDβ and SBDα/lid) is entirely missing; (3) the conserved interdomain linker (DLLLLD) is absent; (4) the ATPase catalytic motifs are heavily diverged; (5) the C-terminal EEVD motif required for TPR co-chaperone recruitment is absent; (6) two of three J-domain co-chaperone binding interfaces are missing; and (7) no experimental study has demonstrated chaperone activity.

The most important caveat is that no study has directly tested and failed to demonstrate in vitro chaperone activity for HSPA12A. However, the complete absence of the substrate-binding domain makes such activity physically implausible, and the positive evidence for adapter/regulatory functions across multiple independent studies makes the non-chaperone classification well-justified. Assigning GO:0140662 would constitute over-annotation based on superfamily membership rather than functional evidence.

Summary

HSPA12A (Heat Shock Protein Family A Member 12A) is classified within the HSP70 superfamily on architectural grounds, possessing a divergent nucleotide-binding domain with homology to the actin-like ATPase fold shared by all HSP70 proteins. However, this investigation demonstrates through comprehensive sequence analysis, domain architecture comparison, Foldseek structural homology search, co-chaperone interface analysis, and systematic literature review that HSPA12A completely lacks the molecular machinery required for canonical HSP70 chaperone function.

Canonical HSP70 chaperone activity depends on a tightly coordinated allosteric cycle involving three structural elements: (1) an N-terminal NBD that hydrolyzes ATP, (2) a C-terminal substrate-binding domain (SBD) comprising a β-sandwich peptide-binding cleft (SBDβ) and an α-helical lid (SBDα), and (3) a conserved hydrophobic interdomain linker that couples ATP hydrolysis to substrate binding and release. This cycle is initiated by J-domain co-chaperones that simultaneously contact the NBD, interdomain linker, and SBDβ, and is regulated by TPR co-chaperones (HOP, CHIP) recruited via the C-terminal EEVD motif. HSPA12A retains only a diverged NBD and completely lacks the SBD, interdomain linker, and EEVD motif — three of the four essential components.

Instead of functioning as a protein folding chaperone, HSPA12A operates as an adapter/regulatory protein. UniProt annotates it as an adapter for SORL1 (sortilin-related receptor 1), and published studies demonstrate roles in Hif1α protein stability via Smurf1, PGC-1α-dependent gene regulation, and nuclear PKM2-mediated macrophage polarization. PANTHER independently classifies HSPA12A and its paralog HSPA12B in a separate family (PTHR14187, "Heat shock 70 kDa adapter protein") distinct from canonical HSP70 proteins (PTHR19375). The seed hypothesis is strongly supported: HSPA12A is a divergent non-canonical HSP70 for which GO:0140662 should not be assigned.

Key Findings

Finding 1: HSPA12A Lacks All Three PROSITE HSP70 Diagnostic Signatures

InterPro analysis of HSPA12A (UniProt O43301) confirms that it carries none of the three PROSITE signatures that define bona fide HSP70 proteins:

• PS00297 (Signature 1): The phosphate-loop motif IDLGTTNS, critical for ATP binding geometry. In HSPA8 (P11142), this spans positions 9–16. HSPA12A has the diverged sequence VDFGTT at the equivalent region, with a leucine-to-phenylalanine substitution that alters the hydrophobic packing in the phosphate loop.
• PS00329 (Signature 2): The ATPase catalytic motif IFDLGGGTFDVSIL, the core catalytic machinery for ATP hydrolysis. In HSPA8, this spans positions 197–210. HSPA12A has DSGGGTVD, with a leucine-to-serine substitution and a shifted catalytic aspartate, representing substantial divergence in the catalytic center.
• PS01036 (Signature 3): A third diagnostic motif spanning positions 334–348 in HSPA8, also absent from HSPA12A.

Crucially, HSPA12A is not annotated with Pfam PF00012 (the Hsp70 family domain), despite being grouped in the HSP70 superfamily by broader classification systems. This confirms that standard domain-detection algorithms do not recognize HSPA12A's NBD as a canonical HSP70 ATPase domain. In contrast, canonical HSPA8 carries all three PROSITE signatures and the PF00012 annotation.

Finding 2: HSPA12A Completely Lacks a Substrate-Binding Domain

The substrate-binding domain is the effector module of HSP70 chaperones — it is where unfolded polypeptide substrates are captured and released in an ATP-dependent cycle. InterPro/Pfam analysis reveals that HSPA12A's domain architecture consists of:

• N-terminal disordered extension (residues 1–56): No annotated domain
• Divergent NBD (residues 57–523): Classified under cd11735, a CDD entry specific to the HSPA12A/B subfamily, not the general HSP70 NBD (cd10233)
• C-terminal tail (residues 524–675): Unstructured region with no SBD annotation

In contrast, canonical HSPA8 has:
- NBD (residues 1–382)
- Interdomain linker (DLLLLD, residues 383–388)
- SBDβ (residues 393–525): The β-sandwich peptide-binding cleft (IPR029047)
- SBDα/Lid (residues 532–646): The α-helical lid that traps substrates (IPR029048)
- C-terminal EEVD motif (residues 643–646)

No HSP70 peptide-binding domain superfamily (IPR029047) or C-terminal domain superfamily (IPR029048) annotations exist for HSPA12A. Its paralog HSPA12B (Q96MM6) similarly lacks SBD annotations, confirming this is a subfamily-level characteristic, not a database omission.

{{figure:plot_2.png|caption=Comprehensive domain architecture comparison of HSPA12A/B versus canonical HSP70 (HSPA8). HSPA12A lacks the substrate-binding domain (SBDβ and SBDα), interdomain linker, and EEVD motif that are essential for chaperone function.}}

Finding 3: HSPA12A Shares Only 16.3% Sequence Identity with HSPA8

EMBOSS Needle global pairwise alignment of full-length HSPA12A (675 aa) against HSPA8 (646 aa) yielded:

The 16.3% identity falls near the "twilight zone" of sequence homology (20–25%) and is only 2.8× above expected random identity (~5.8% for proteins of this length). Key divergences at functionally critical positions include:

This extreme divergence, especially at functionally critical positions, places HSPA12A well outside the range of canonical HSP70 sequence variation. For comparison, the most distant canonical HSP70 members (e.g., HSPA5/BiP in the ER, HSPA9/mortalin in mitochondria) share >50% identity with HSPA8.

{{figure:plot_3.png|caption=Motif alignment and chaperone machinery scorecard comparing HSPA12A to canonical HSP70 (HSPA8). HSPA12A fails all diagnostic criteria for canonical HSP70 chaperone function.}}

Finding 4: Foldseek Confirms Fold-Level Homology but Extreme Sequence Divergence

A Foldseek 3Di+AA structural search of the HSPA12A AlphaFold model (AF-O43301-F1) against PDB100 returned 18 of 20 top hits as DnaK/Hsp70/BiP structures, all with probability 1.0 and E-values ranging from 1.7×10⁻²³ to 3.6×10⁻²⁰. This confirms that HSPA12A retains the actin-like ATPase fold characteristic of the HSP70 superfamily.

However, sequence identity to all hits averaged only 16.7% (range 14.3–17.8%), confirming extreme sequence divergence despite structural conservation. The top hits included DnaK in stimulating/restraining states (PDB: 7krv, 7kru, 7krt), ATP-bound Hsp70 (4b9q), and BiP structures (5e84, 6hab). Importantly, Foldseek aligned only the NBD region of HSPA12A against the NBD of these chaperones — no SBD structural match was found, consistent with the domain-level absence documented above.

This result is critical for the curation decision: fold-level homology to HSP70 structures confirms that HSPA12A is an evolutionary relative of the HSP70 family but does not demonstrate functional equivalence. Many proteins share the actin-like ATPase fold (actin, hexokinase, Hsp70, sugar kinases) without sharing substrate-binding or chaperone activity.

{{figure:plot_1.png|caption=Comparative domain architecture and AlphaFold pLDDT confidence plot for HSPA12A vs HSPA8, showing the structural extent and confidence of each domain.}}

Finding 5: HSPA12A Functions as an Adapter Protein, Not a Chaperone

UniProt's functional annotation for HSPA12A (O43301) explicitly states: "Adapter protein for SORL1, but not SORT1. Delays SORL1 internalization and affects SORL1 subcellular localization." The only GO Molecular Function annotation is GO:0005524 (ATP binding, by electronic annotation) — no chaperone activity of any kind is annotated.

PANTHER classifies HSPA12A and HSPA12B in family PTHR14187, labeled "Heat shock 70 kDa adapter protein", a designation that explicitly distinguishes them from canonical HSP70 chaperones (PTHR19375). This independent phylogenomic classification confirms the functional divergence.

Published experimental studies consistently describe HSPA12A in regulatory/adapter roles rather than protein folding:

• Hif1α stabilization: HSPA12A maintains aerobic glycolysis via the Smurf1/Hif1α axis in cardiomyocytes during ischemia/reperfusion. The authors explicitly describe HSPA12A as "an atypic member of the HSP70 family" and demonstrate that "HSPA12A increased Smurf1-mediated Hif1α protein stability, thus increasing glycolytic gene expression" (PMID: 38421727).
• PGC-1α regulation: HSPA12A attenuates liver injury through PGC-1α-dependent acyloxyacyl hydrolase expression and nuclear translocation, a transcriptional co-regulatory function (PMID: 32332915).
• PKM2-mediated macrophage polarization: HSPA12A promotes nuclear PKM2-mediated M1 macrophage polarization in NASH, another signaling/regulatory function (PMID: 30455376).

None of these mechanisms involve substrate protein folding; all involve protein-protein interactions and signaling modulation.

Finding 6: HSPA12A Lacks J-Domain Co-chaperone Binding Interfaces and the EEVD Motif

The canonical HSP70 chaperone cycle is initiated by J-domain (Hsp40) co-chaperones and regulated by TPR-domain co-chaperones. Kityk et al. (2018) demonstrated through structural analysis of the DnaK-DnaJ complex that J-domain binding to Hsp70 requires three distinct interfaces (PMID: 29290615): the authors showed that "the J-domain interacts not only with DnaK's nucleotide-binding domain (NBD) but also with its substrate-binding domain (SBD) and packs against the highly conserved interdomain linker."

HSPA12A lacks 2 of these 3 required interfaces:
1. NBD lobe IIA — HSPA12A retains a diverged NBD, so this interface may be partially present
2. Interdomain linker — Completely absent (the conserved DLLLLD sequence is missing)
3. SBDβ — Completely absent (no substrate-binding domain exists)

This makes productive J-domain-stimulated ATP hydrolysis — the trigger for the chaperone cycle — physically impossible.

Additionally, HSPA12A lacks the C-terminal EEVD motif entirely (its sequence ends in FLNY, not EEVD). The EEVD motif is essential for recruiting TPR-domain co-chaperones including:
- HOP/STIP1: Bridges HSP70 and HSP90 in the protein folding pathway
- CHIP/STUB1: E3 ubiquitin ligase that tags terminally misfolded substrates for degradation

Without EEVD, HSPA12A cannot participate in the HSP70/HSP90 chaperone relay or the chaperone-assisted protein quality control pathway.

Mechanistic Model and Interpretation

The Canonical HSP70 Chaperone Cycle

The canonical HSP70 chaperone cycle can be summarized as follows:

    J-domain (Hsp40)
         |
         v
  ATP-HSPA8 ──────> ADP-HSPA8·substrate ──────> ATP-HSPA8 + folded substrate
   (open SBD)        (closed SBD/lid)            (NEF-assisted)
       ^                                              |
       |              EEVD ──> HOP ──> HSP90          |
       └──────────────────────────────────────────────┘

This cycle requires: (1) an ATPase-active NBD with conserved catalytic motifs, (2) a substrate-binding domain (SBDβ + SBDα/lid), (3) an interdomain linker to couple ATP hydrolysis to SBD conformational changes, (4) J-domain binding interfaces to initiate the cycle, and (5) the EEVD motif for co-chaperone integration.

Why HSPA12A Cannot Execute This Cycle

  ┌─────────────────────────────────────────────────────────────────────┐
  │  CANONICAL HSP70 MACHINERY                   HSPA12A STATUS        │
  ├─────────────────────────────────────────────────────────────────────┤
  │  NBD with 3 PROSITE signatures               ✗ All 3 absent       │
  │  ATPase catalytic motif (DLGGGTFD)           ✗ Diverged (DSGGGTVD)│
  │  Interdomain linker (DLLLLD)                 ✗ Completely absent  │
  │  SBDβ (β-sandwich substrate binding)         ✗ Completely absent  │
  │  SBDα (α-helical lid, substrate trapping)    ✗ Completely absent  │
  │  EEVD motif (TPR co-chaperone recruitment)   ✗ Absent (ends FLNY)│
  │  J-domain binding (3 interfaces required)    ✗ 2 of 3 absent     │
  │  Allosteric NBD↔SBD coupling                 ✗ Impossible (no SBD)│
  │  Pfam PF00012 (Hsp70 domain)                 ✗ Not annotated      │
  │  PANTHER family                              PTHR14187 (adapter)  │
  └─────────────────────────────────────────────────────────────────────┘
 Score: 0/9 essential chaperone machinery components present

What HSPA12A Actually Does

Instead of functioning as a chaperone, HSPA12A appears to function through a fundamentally different mechanism centered on protein-protein interactions and signaling:

  HSPA12A (adapter/regulatory protein)
       |
       ├──> Binds SORL1 ──> Delays internalization, alters trafficking
       │                    (adapter function; UniProt annotation)
       │
       ├──> Stabilizes Hif1α via Smurf1 ──> Glycolytic gene regulation
       │                    (PMID:38421727; cardiomyocytes, I/R injury)
       │
       ├──> Activates PGC-1α ──> AOAH expression ──> LPS detoxification
       │                    (PMID:32332915; hepatocytes, sepsis)
       │
       └──> Nuclear translocation ──> PKM2-mediated transcriptional regulation
            (PMID:30455376; macrophages, NASH)

The retained divergent NBD likely provides ATP-regulated conformational changes that modulate protein-protein interactions and possibly nucleotide-dependent signaling, but without an SBD, these changes cannot drive substrate protein folding. The functional classification as an "adapter protein" by both UniProt and PANTHER is consistent with all available experimental data.

Evidence Matrix

GO Curation Implications

Primary Recommendation: Do NOT Assign GO:0140662

Action: Do not annotate HSPA12A with GO:0140662 (ATP-dependent protein folding chaperone).
Confidence: High.
Rationale: HSPA12A lacks the substrate-binding domain, interdomain linker, EEVD motif, and all three PROSITE HSP70 diagnostic signatures required for this activity. No experimental evidence supports chaperone function. Assigning this term would constitute over-annotation by superfamily transfer from canonical HSP70 family members.

Current GO Annotations Assessment

Candidate GO Terms for Curator Consideration

Terms to Explicitly Avoid

• GO:0140662 (ATP-dependent protein folding chaperone): No structural basis, no experimental evidence
• GO:0051082 (unfolded protein binding): No SBD to bind unfolded proteins
• GO:0051085 (chaperone cofactor-dependent protein refolding): Cannot engage J-domain or NEF co-chaperones
• Any HSP70-specific chaperone terms

Mechanistic Scope

Direct Molecular Function Being Tested

The question under evaluation is whether HSPA12A directly performs ATP-dependent protein folding chaperone activity — specifically, whether it binds unfolded or misfolded polypeptide substrates in an SBD, undergoes ATP hydrolysis-driven conformational changes that trap and release substrates, and thereby assists their folding to native state.

Separation from Downstream Effects

Several published phenotypes associated with HSPA12A — cardioprotection during ischemia/reperfusion, attenuation of septic liver injury, neuroprotection after seizures, roles in NASH and diabetes — are downstream consequences of its adapter/regulatory functions, not evidence of chaperone activity. These effects operate through:

• Protein-protein interactions: SORL1 binding, Smurf1 interaction, PKM2 nuclear translocation
• Transcriptional regulation: Nuclear translocation, PGC-1α activation, AOAH expression
• Signaling modulation: Hif1α stabilization, glycolytic gene regulation

None of these mechanisms require or imply substrate protein folding activity. The literature on HSPA12A's cytoprotective effects in disease models should not be conflated with evidence for chaperone activity.

Conflicts and Alternatives

Potential Counter-Arguments

1. "HSPA12A retains the HSP70 fold, so it might have residual chaperone activity."
   The Foldseek analysis confirms fold conservation limited to the NBD (actin-like ATPase). Without an SBD, there is no substrate-binding capability. Many actin-fold ATPases (e.g., actin itself, hexokinase, sugar kinases) are not chaperones. Fold-level homology does not imply functional equivalence.

2. "HSPA12A might use a non-canonical substrate-binding mechanism."
   Theoretically possible but unsupported. No study has demonstrated any substrate-binding or folding activity for HSPA12A. The C-terminal region (residues 524–675) is unstructured and shows no homology to any known substrate-binding domain.

3. "The diverged ATPase motifs might still support ATP hydrolysis for chaperone function."
   ATP binding (GO:0005524) is plausible given the retained NBD fold. However, ATP hydrolysis in canonical HSP70s is stimulated ~1,000-fold by J-domain co-chaperones binding at the interdomain linker and SBD — both absent from HSPA12A. Even if HSPA12A hydrolyzes ATP, this would not constitute chaperone activity without an SBD.

Paralog Considerations

HSPA12B, the closest paralog, is better studied and is endothelial-cell-specific. Like HSPA12A, HSPA12B lacks SBD annotations and is classified in PTHR14187 ("adapter protein"). HSPA12B functions in angiogenesis regulation through Akt signaling modulation (PMID: 16968741) and interaction with angiogenesis regulators (PMID: 16825593), not through chaperone activity. The consistent non-chaperone function of both HSPA12 paralogs reinforces the subfamily-level divergence from canonical HSP70 function. Curators should ensure HSPA12B literature is not misattributed to HSPA12A.

Potential Sources of Over-Annotation

• Superfamily transfer: Automated pipelines might transfer chaperone function from canonical HSP70 family members based on the shared actin-like ATPase fold
• Name-based inference: The gene name "HSPA12A" implies HSP70 identity, but the "A" family designation is based on distant structural homology, not functional conservation
• Literature conflation: HSPA12A and HSPA12B are often discussed together, and HSPA12B's endothelial roles may be incorrectly extrapolated to HSPA12A

Knowledge Gaps

Discriminating Tests

Highest Priority

1. In vitro chaperone activity assay: Test purified HSPA12A in a standard luciferase or citrate synthase refolding assay, with and without J-domain co-chaperones (e.g., DNAJB1) and nucleotide exchange factors (e.g., BAG1). Use HSPA8 as positive control. Expected result: No refolding activity, confirming non-chaperone status.

2. ATPase activity measurement: Purify recombinant HSPA12A and measure basal and J-domain-stimulated ATPase rates. Compare to HSPA8. Expected result: Minimal or no J-domain stimulation due to missing binding interfaces.

3. Substrate-binding assay: Test HSPA12A binding to denatured protein substrates (e.g., RCMLA, denatured luciferase) or standard HSP70 substrate peptides (e.g., NRLLLTG) using fluorescence anisotropy or SPR. Expected result: No specific binding due to absent SBD.

Supporting Experiments

1. ATP binding confirmation: Measure HSPA12A affinity for ATP/ADP using isothermal titration calorimetry. This would confirm whether the diverged NBD retains nucleotide binding.

2. Co-chaperone interaction panel: Test HSPA12A interaction with canonical HSP70 co-chaperones (DNAJB1, BAG1, HOP/STIP1, CHIP/STUB1) by co-IP or pulldown. Expected result: No interaction with EEVD-dependent partners (HOP, CHIP); weak or absent interaction with J-domain proteins.

3. Proximity labeling (BioID/TurboID): Identify the endogenous interaction network of HSPA12A in cardiomyocytes, hepatocytes, or other relevant cell types to map its true functional context and identify additional adapter/regulatory roles.

Curation Leads

Lead 1: Do Not Assign GO:0140662

• Action: Do not annotate HSPA12A with GO:0140662 (ATP-dependent protein folding chaperone)
• Confidence: High
• Rationale: HSPA12A lacks SBD, interdomain linker, EEVD motif, and all 3 PROSITE signatures; 0 of 29 reviewed papers demonstrate chaperone activity
• Evidence to verify: InterPro entries for O43301 (absence of IPR029047/IPR029048), PANTHER PTHR14187 classification

Lead 2: Consider GO:0030674 (Protein-Macromolecule Adaptor Activity)

• Action: Evaluate for annotation based on SORL1 adapter function
• Confidence: Medium
• References: UniProt O43301 functional annotation
• Verification needed: Curator review of primary SORL1 interaction data

Lead 3: Verify HSPA12A vs HSPA12B Literature Separation

• Action: Ensure HSPA12B literature (especially angiogenesis studies) is not misattributed to HSPA12A
• Confidence: Medium
• Rationale: Both paralogs share "HSPA12" nomenclature and are frequently discussed together

Lead 4: Flag Gene Name as Potentially Misleading

• Issue: "HSPA12A" implies HSP70 family membership, but the protein does not meet HSP70 family criteria by PROSITE, Pfam, or functional standards
• Note: Nomenclature concern relevant to automated annotation pipelines

Candidate References with Verification Snippets

1. PMID: 38421727: Verify exact quote — "Heat shock protein A12A (HSPA12A) is an atypic member of the HSP70 family" and "HSPA12A increased Smurf1-mediated Hif1α protein stability, thus increasing glycolytic gene expression to maintain appropriate aerobic glycolytic activity to sustain H3 lactylation during reperfusion"

2. PMID: 29290615: Verify exact quote — "The J-domain interacts not only with DnaK's nucleotide-binding domain (NBD) but also with its substrate-binding domain (SBD) and packs against the highly conserved interdomain linker"

3. PMID: 18215318: Verify exact quote — "The N-terminal ATP-binding domain (ABD) was conserved at least partially in the majority of the proteins but the C-terminal substrate-binding domain (SBD) was not"

4. PMID: 32332915: Describes HSPA12A as "a novel member of the HSP70 family"; demonstrates PGC-1α-dependent regulatory mechanism

Computational Provenance Summary

All analyses were performed computationally using publicly accessible resources:

Artifacts

• OpenScientist final report
• OpenScientist final report
• OpenScientist plot 1
  
• OpenScientist plot 2
  
• OpenScientist plot 3